Office
10080 E Lippincott Blvd, Davison, MI 48423
(810) 653-1130
Internal medicine in Davison, MI · McLaren Flint
No reviews yet. Be the first to review
10080 E Lippincott Blvd, Davison, MI 48423
(810) 653-1130
In 2025, drug and medical-device companies reported $233 in general payments to Maria E Goleba (12 payments). Largest: Novo Nordisk Inc ($71.88); ABBVIE INC. ($40.87); AstraZeneca Pharmaceuticals LP ($34.96). Reported under the federal Open Payments program.
2024 Medicare-billed services:
Billed services and units in Original Medicare Part B, 2024.
Scroll the table sideways to see every column.
| HCPCS | Billed services / units | Beneficiaries in this row | Service description (English) | Billing setting |
|---|---|---|---|---|
| 93010 | 69 | 65 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Non-facility |
| 99204 | 11 | 11 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | Non-facility |
| 99213 | 184 | 141 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Non-facility |
| 99214 | 328 | 206 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Non-facility |
| 99215 | 36 | 33 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | Non-facility |
| G0439 | 86 | 86 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Non-facility |
The office is at 10080 E Lippincott Blvd, Davison, MI 48423.
The office phone is (810) 653-1130.
Specialty: Internal medicine.
Yes. Maria E Goleba billed Original Medicare Part B services in 2024 (see Medicare activity above).
Maria E Goleba is affiliated with McLaren Flint (Flint, MI); McLaren Lapeer Region (Lapeer, MI); Montrose Regional Health (Montrose, CO).
All reviews are moderated. Review policy